Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

CVS Drops Obesity Drug; Once-Weekly Growth Hormone; WeightWatchers' Bankruptcy. Story by Kristen Monaco • 2d. M any patients may have to switch obesity drugs now that CVS Caremark opted to stop ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

CVS Health Corp.’s chief medical officer said the cost of buzzy new medicines for weight loss and diabetes has gotten out of control. “The prices are $1,000 a month,” Sree Chaguturu said ...

CVS Health opts for Wegovy and Saxenda on its formulary; Zepbound excluded. Millions affected as coverage choices impact cost and access to obesity drugs. Skip Navigation ...

Pharmacy giant CVS Health on Tuesday announced an overhaul of its drug-pricing model to boost transparency amid scrutiny of the soaring cost for medications. The new system, called CVS CostVantage,… ...

Pharmalittle: We’re reading about CVS exploring a breakup, obesity drug coverage, and more. J&J backs down on plan to switch how it pays some 340B hospitals. Manage alerts for this article; ...

The obesity drug price wars are finally starting. After being publicly lambasted for the high cost of their weight-loss shots, two of world’s biggest drugmakers — Eli Lilly & Co. and Novo ...

CVS Health Corp.’s chief medical officer said the cost of buzzy new medicines for weight loss and diabetes has gotten out of control. “The prices are $1,000 a month,” Sree Chaguturu said ...